Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
17 hedge funds and large institutions have $3.54M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2013 Q2 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
6,200% more call options, than puts
Call options by funds: $63K | Put options by funds: $1K
Top Buyers
Top Sellers
CORV Hedge Fund Activity: Q2 2013 in Review
17 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2013, worth a combined $3.54M.
Buyers outnumbered sellers: 17 funds opened new CORV positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
- 17 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $3.54M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2013.
- 17 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2013 and 0 closed out, a net change of +17 holders.
Based on aggregated 13F filings for Q2 2013.